Free Trial!
Today’s Best Stocks To Trade! Click Here
Stock Profiler.US, LLC welcomes Investors and Companies alike to join us in our pursuit of excellence. Companies who want to broadcast their message are encouraged to contact us at www.stockprofiler.us. Sign up for our Free Newsletter at www.stockprofiler.us.
-------------------------------------------
Green Globe International, Inc. (OTCBB: GGLB | Quote | Chart | News | PowerRating) closed at $0.0032 Monday, trading 65,541,655 shares.
Company News- July 7, 2008: Green Globe International, Inc. Announces Initial Agreement With PA Consulting Group for Collaboration on Sustainability Projects
Green Globe International, Inc. (OTCBB: GGLB), which owns the Green Globe brand, the premier international green brand focused on sustainability and carbon neutrality programs, announced yesterday that it has entered into an initial agreement in the form of a Memorandum of Understanding with PA Consulting Group, a leading global management consultancy company. Green Globe International and PA Consulting Group plan to cooperate in several specified areas related to the delivery of sustainability programs under the Green Globe banner. Under terms of the MOU, the areas of collaboration between PA Consulting Group and Green Globe International, Inc., include, but are not limited to: 1) identify potential tourism destinations (e.g., countries, territories, municipalities, and resort areas) for Green Globe International programs; 2) secure the support and participation of key stakeholders in the destination; 3) design and develop a destination-specific Sustainability and Carbon Neutrality Plan; 4) work with Green Globe International to secure funds to finance the implementation of the Sustainability and Carbon Neutrality Plan; 5) manage the implementation of the Sustainability and Carbon Neutrality Plan; 6) monitor and report progress toward key sustainability and carbon generation indicators for Energy consumption; Waste production; Water usage; Chemical usage; Community Engagement, and local economic benefit; 6) certify that communities and businesses are compliant with the Green Globe Benchmarking and Certification Programs available; and 7) provide an annual review to confirm compliance with Benchmarking Standards which qualify for Certification. After meetings with Caribbean tourism organizations and officials, Green Globe International recently announced plans to deliver sustainability and carbon neutrality solutions for the region. Green Globe International will further seek to expand these programs to countries and destinations worldwide. Steven R. Peacock, chief executive officer and managing director of Green Globe International, Inc., commented, "We are extremely pleased to have established a relationship with PA Consulting Group and believe that they will be a tremendous partner for Green Globe and will assist greatly in the implementation of our sustainability programs. "The support of PA Consulting Group is expected to contribute significantly to the success of the Green Globe program, particularly as we seek to expand the awareness of our Sustainability and Carbon Neutrality Plans for destinations and countries that are concerned with the quality of their environment. As this agreement details, we also anticipate that PA will play an integral role in the implementation of Green Globe programs to the participating destinations and countries." According to Bill Meade, Partner with PA Consulting Group, "Green Globe has provided a roadmap for governments, companies, and communities interested in applying environmental and social sustainability programs to the tourism sector." PA has helped over 50 hotels, resorts and tourism attractions become Green Globe benchmarked and certified, and three tourism destinations become Green Globe benchmarked. PA was instrumental in introducing Green Globe to Caribbean and Middle East tourism markets, including helping the first four hotels in the world, all from Jamaica, become Green Globe certified. "We are excited about the inclusion of carbon neutrality to the Green Globe program as the global tourism industry, host country governments, and private businesses are seeking to reduce their 'carbon footprint' and participate in international carbon trading and financing schemes," Mr. Meade added. The World Travel and Tourism Council (WTTC) established Green Globe in 1992 as a response to the United Nations Rio de Janeiro Earth Summit, where 182 Heads of State endorsed the Agenda 21 principles of Sustainable Development. Green Globe is the only international sustainability program based on Agenda 21 principles. Green Globe International (www.greenglobeint.com) encourages all shareholders and others interested in following the progress of the company to subscribe to receive email alerts whenever new information is made public. To subscribe, please visit http://www.greenglobeint.com/stayconnected/email/.
About PA Consulting Group
PA Consulting Group is an independent, employee-owned, global firm of 3,000 talented individuals, operating from offices across the world, in Europe, North America, Latin America, Asia, and Oceania. PA has won numerous awards for delivering complex and highly innovative assignments, run one of the most successful venture programmes in the consulting industry, technology development capability that few firms can match, deep expertise across key industries and government, and a unique breadth of skills from strategy to IT to HR to applied technology. PA has earned a worldwide reputation for transforming the performance of organizations.
About Green Globe International, Inc.
Green Globe International, Inc. is the majority owner of Green Globe, Ltd., a British company that owns the Green Globe brand, the premier international brand for sustainable travel, tourism and related green businesses. Green Globe's worldwide network extends across 30 countries. For information on Green Globe's benchmarking and certification please visit http://www.ec3global.com/products-programs/green-globe/Default.aspx. For more information on Green Globe International, please visit www.greenglobeint.com.
-------------------------------------------
Franklin Mining, Inc. (PINKSHEETS: FMNJ | Quote | Chart | News | PowerRating) (FRANKFURT: FMJ) closed at $0.0019 Monday, trading 73,997,378 shares.
Company News- July 8, 2008: Franklin Expands US Energy Subsidiary and Establishes Franklin Mining Colombia LTDA
Franklin Mining, Inc. (PINKSHEETS: FMNJ | Quote | Chart | News | PowerRating) (FRANKFURT: FMJ) Chairman and President, William A. Petty, announced earlier today that ongoing negotiations for US energy projects have resulted in a significant change in previously announced plans for the company's US energy division. Franklin Mining, Inc. has retained full ownership of the recently formed subsidiary, Franklin Oil & Gas, Inc., and is prepared to begin work in west Texas. Mr. Petty also announced that incorporation documents have been prepared for formation of Franklin Mining Colombia LTDA and all requested information has been submitted to ECOPETROL (Colombia's national oil company) to register future crude oil sales.
About Franklin Mining, Inc
Franklin Mining, Inc. has mining and energy interests in the United States and Bolivia as well as energy interests in Argentina. Franklin Mining, Bolivia is a wholly owned subsidiary. Franklin Mining, Inc. holds 51% ownership in both Franklin Oil & Gas, Bolivia S.A. and Franklin Oil & Gas, Argentina S.A. Additional information is available at www.FranklinMining.com.
-------------------------------------------
Patient Access Solutions Inc. (OTCBB: PASO | Quote | Chart | News | PowerRating) closed at $0.97 Monday, trading 497,400 shares.
Company News- July 8, 2008: Patient Access Solutions Inc. Corporate Update
Earlier today the following was announced:
Bruce Weitzberg, President and CEO of Patient Access Solutions Inc. (OTCBB: PASO), a leading provider of healthcare/financial processing solutions for the healthcare, homecare and dental industries , would like to present its shareholders with a Corporate update. Sales for the six month period ending April 30, 2008 compared to the same period last year (2007) increased by 80%. PAS has hired of a new VP of Sales with over 18 years of technology industry experience In early June 2008, PAS completed the second layer of integration between digital paper technology and the PAS web portal -- thereby, allowing full, seamless, eligibility and benefit verification transactions, from paper/pen through the PAS network to over 750 insurance companies and plans. In May 2008, PAS completed their new updated interactive claims analyzer web portal. This new portal allows healthcare providers to monitor claims status from submission to payment, all from their desktop computer. Additionally PAS has instituted ERA (Electronic Remittance Advice) which allows healthcare providers to receive payments from insurance companies via electronic wire in lieu of paper checks. We recently started 3 different pilot programs with 3 major Home Healthcare Agencies located in North America, with over 35,000 nurses combined, and so far the feedback has been extremely positive. We are currently beginning contract discussions with one of the major Home Healthcare Agencies. Bruce Weitzberg stated, "We will continue to keep you updated as our business progresses. As always, we appreciate your ongoing support and look forward to a very successful 2008!"
About Patient Access Solutions Inc. (www.pashealth.com)
Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. The PASHealth Web Portal System and terminal-based solutions offer electronic medical eligibility, electronic referrals and service authorizations, electronic claims processing, drug formularies, electronic prescriptions, electronic medical records and patient data, automating the labor-intensive and expensive manual process currently used by many facilities and healthcare providers. Our D-PAS product utilizes digital pen & paper technology, to capture handwritten information from the doctor or office personnel, transfer it into a digital form into the PAS web portal and utilize the data to initiate workflows in a secure environment. A patient's medical history and patient records are used to initiate necessary workflows within the web portal, securely and much more efficiently, empowering the healthcare business process. In addition, the Web Portal System offers a complete suite of self pay receivable management solutions for the healthcare facilities.
-------------------------------------------
AspenBio Pharma, Inc. (NASDAQ: APPY | Quote | Chart | News | PowerRating) closed at $5.86 Monday, trading 51,800 shares.
Company News- July 8, 2008: Michael R. Merson Joins AspenBio Pharma's Board of Directors
Earlier today the following was announced:
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has appointed Michael R. Merson as a new independent member of its board of directors. This appointment brings the total number of company directors to seven, with five serving independently. Merson is a highly seasoned health care executive, having founded and managed several healthcare organizations, from hospitals to health insurers. Since 2004, he has served as chairman of CareFirst Blue Cross/Blue Shield, the 16th largest health insurer in the United States, with annual revenues of approximately $7.0 billion and more than 3.2 million insured individuals. CareFirst is part of the BlueCross/Blue Shield group of insurance providers which collectively covers more than 100 million people in the United States. Merson has a 30-year record of growth and development in the health care industry, including as president and CEO of Franklin Square Hospital (1982-1987), various positions including president and CEO of Helix Health, Inc. (1987-1998), and president of MedStar Health (1998-1999). Through Michael R. Merson, LLC and Yaffe & Company, he currently provides consulting services to primarily healthcare related enterprises, focusing on mergers and acquisitions, goal setting, business and governance issues, and executive compensation and benefits. Merson has been active with the Maryland Hospital Association, including participating on its executive council and receiving its Distinguished Service Award. He also served as its chair of the professional practices committee and the rate regulation council. Merson has served on the boards of the Maryland Hospital Education Institute and the National Blood Association, in addition to serving on the board and executive committee of AmHS/Premier, Inc. Merson received his MBA in Health Care Administration from The George Washington University. "We are pleased to have someone with Michael's knowledge, wisdom and experience, join our board of directors," said Greg Pusey, AspenBio Pharma's chairman. "His healthcare expertise from a hospital and insurance perspective, combined with hands-on experience in founding and growing successful organizations, greatly benefits our board at this important stage in our development and as we pursue many exciting opportunities."
About AspenBio Pharma
AspenBio Pharma is an emerging bio-pharmaceutical company dedicated to the discovery; development, manufacture, and marketing of novel proprietary products, including those that enhance the reproductive efficiency of animals and that have large worldwide market potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and testing of its two first-generation blood-based human diagnostic tests designed to rapidly help diagnose or rule out appendicitis in patients complaining of abdominal pain. For more information, go to www.aspenbiopharma.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Stockprofiler.US affiliates has not been compensated for services rendered; Stockprofiler.US affiliates is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers, go to www.stockprofiler.us) (disclaimers).
CONTACT: StockProfiler.US e-mail: info@stockprofiler.us WWW: http://www.stockprofiler.us
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
